PFE  Pfizer Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

193.1B

Vuru Grade

56.97/100

Current Price

$30.25
+0.16 (+0.53%)

Growth Price

$28.24
Overvalued by 6.63%

Stability Price

$7.93
Overvalued by 73.79%

Company Metrics

  • 9.43 P/E
  • 3.72 P/S
  • 2.52 P/B
  • 3.191 EPS
  • 15.13% Cash ROIC
  • 0.95 Cash Ratio
  • 0.98 / 3.26% Dividend
  • 28.80M Avg. Vol.
  • 7.87B Shares
  • 193.1B Market Cap.

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.